Just published!!! Our review on strategies to mitigate infection risk with complement inhibitors, highlighting real-world gaps in guidance, where evidence is limited and clinical judgement is key - vaccines, antibiotics, specialist consults @CIDJournal pubmed.ncbi.nlm.nih.gov/41711415/ This “complements” our earlier paper in @asnpublications (which outlined infection risk broadly in kidney disease) by digging into how to operationalize prevention in practice! pubmed.ncbi.nlm.nih.gov/41649885/ #complementinhibitors #patientsafety

@anuja_java @CIDJournal Congrats on the publication and thanks for sharing practical guidance clinicians can use right away.